$TGTX Headlines Strength Seen in TG Therapeuti
Post# of 88914
Posted On: 06/24/2014 10:43:21 AM
$TGTX Headlines
Strength Seen in TG Therapeutics, Inc. (TGTX) as Stock Rallies 12.94% - Tale of the Tape 8:44 a.m. Today - Zacks.com
A new partnership to develop IRAK-4 inhibitors 7:41 a.m. Today - Seeking Alpha
TG Therapeutics (TGTX) Crumbles: Stock Falls by 6.6% - Tale of the Tape 8:41 a.m. June 19, 2014 - Zacks.com
TG Therapeutics (TGTX) Catches Eye: Stock Surges 20.8% in Session - Tale of the Tape 8:37 a.m. June 13, 2014 - Zacks.com
Interim Phase 2 results for TG Therapeutics' cancer mAb 7:48 a.m. June 13, 2014 - Seeking Alpha
Bullish chart action for TG Therapeutics 5:23 p.m. June 12, 2014 - Seeking Alpha
Market Crash in the Cards? 3 Stocks to Book Profits - Investment Ideas 4:06 a.m. June 4, 2014 - Zacks.com
TG Therapeutics' (TGTX) CEO Michael Weiss on Q1 2014 Results - Earnings Call Transcript 1:31 p.m. May 13, 2014 - Seeking Alpha
The Recent Performance of 'Baker Brother Biotech Stocks' is Awful 12:23 p.m. April 15, 2014 - TheStreet.com
TG Therapeutics Gets A Triple Thumbs Up From The Baker Brothers 11:23 a.m. March 13, 2014 - Seeking Alpha
TG Therapeutics (TGTX) is Overbought, What's Next? - Tale of the Tape 9:35 a.m. March 13, 2014 - Zacks.com
Is It Too Late to Buy the Rally in Small Caps? 1:00 a.m. March 7, 2014 - InvestorPlace.com
TG Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 1:59 p.m. March 6, 2014 - Seeking Alpha
TG Therapeutics (TGTX) Worth Watching: Stock Up 6.6% - Tale of the Tape 10:25 a.m. Feb. 28, 2014 - Zacks.com
FDA Okays VIVO's Flu Assay, Shares Up - Analyst Blog 6:05 p.m. Jan. 14, 2014 - Zacks.com
TG Therapeutics initiates study of ublituximab/ PI3K Delta inhibitor combo 3:11 p.m. Nov. 25, 2013 - Seeking Alpha
Investments On Biotech's Cutting Edge: Joseph Pantginis 5:41 p.m. Nov. 18, 2013 - Seeking Alpha
TG Therapeutics, Inc. Enters Oversold Territory - Tale of the Tape 9:50 a.m. Nov. 18, 2013 - Zacks.com
TG Therapeutics' CEO Discusses Q3 2013 Results - Earnings Call Transcript 3:49 p.m. Nov. 12, 2013 - Seeking Alpha
10-Q: TG THERAPEUTICS, INC. 4:33 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
TG Therapeutics Completes Global Licensing Agreement With Ligand Pharmaceuticals for the Development of Inhibitors of IRAK4 8:09 a.m. Today - GlobeNewswire
Ligand Signs Global License Agreement with TG Therapeutics for IRAK-4 Inhibitor Program 3:01 a.m. Today - BusinessWire - BZX
TG Therapeutics, Inc. to Present at the 2014 JMP Securities Healthcare Conference 8:31 a.m. June 23, 2014 - GlobeNewswire
Sales, Clinical Hold Removal, Trial Initiations, and Committee Recommendations - Analyst Notes on Geron, Zalicus, Northwest Biotherapeutics, Progenics and TG Therapeutics 5:30 a.m. June 17, 2014 - PR Newswire - PRF
TG Therapeutics, Inc. to Present at the 2014 Wells Fargo Healthcare Conference 4:30 p.m. June 16, 2014 - GlobeNewswire
TG Therapeutics' TG-1101 (Ublituximab) in Combination With Ibrutinib Demonstrates Compelling Clinical Activity and Safety Profile in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) 5:31 a.m. June 13, 2014 - GlobeNewswire
Coronado Biosciences Announces February Inducement Award 4:06 p.m. May 9, 2014 - GlobeNewswire
TG Therapeutics, Inc. Provides Update on a Modified TGR-1202 Formulation and Fed-State Dosing With Data Demonstrating Significantly Higher TGR-1202 Exposure 8:32 a.m. May 8, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Present at the 39th Annual Deutsche Bank Healthcare Conference 8:32 a.m. May 5, 2014 - GlobeNewswire
TG Therapeutics, Inc. Announces Preclinical Poster Presentations for TGR-1202 at AACR 2014 8:32 a.m. April 7, 2014 - GlobeNewswire
TG Therapeutics, Inc. Announces $18.1 Million Underwritten Sale of Common Stock to a Single Institutional Investor 5:13 p.m. March 11, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Present at the 26th Annual ROTH Conference 10:01 a.m. March 10, 2014 - GlobeNewswire
TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results and Business Update 5:07 p.m. March 5, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2013 Financial Results and Business Update 9:31 a.m. March 4, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Present at the 16th Annual BIO CEO & Investor Conference 5:00 p.m. Feb. 7, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference 5:30 p.m. Jan. 13, 2014 - GlobeNewswire
Coronado Biosciences Announces Management Changes 8:00 a.m. Dec. 20, 2013 - GlobeNewswire
TG Therapeutics, Inc. Announces Presentation of Encouraging Clinical Activity of TGR-1202 in an Ongoing Multi-Center Phase I Clinical Study 11:57 a.m. Dec. 9, 2013 - GlobeNewswire
TG Therapeutics, Inc. Launches Combination Clinical Trial of TG-1101 and Ibrutinib in Patients With Select B-Cell Malignancies 9:30 a.m. Dec. 6, 2013 - GlobeNewswire
TG Therapeutics, Inc. Announces Poster Presentations for TGR-1202 at the Upcoming 55th American Society of Hematology Meeting 5:40 p.m. Dec. 5, 2013 - GlobeNewswire
Strength Seen in TG Therapeutics, Inc. (TGTX) as Stock Rallies 12.94% - Tale of the Tape 8:44 a.m. Today - Zacks.com
A new partnership to develop IRAK-4 inhibitors 7:41 a.m. Today - Seeking Alpha
TG Therapeutics (TGTX) Crumbles: Stock Falls by 6.6% - Tale of the Tape 8:41 a.m. June 19, 2014 - Zacks.com
TG Therapeutics (TGTX) Catches Eye: Stock Surges 20.8% in Session - Tale of the Tape 8:37 a.m. June 13, 2014 - Zacks.com
Interim Phase 2 results for TG Therapeutics' cancer mAb 7:48 a.m. June 13, 2014 - Seeking Alpha
Bullish chart action for TG Therapeutics 5:23 p.m. June 12, 2014 - Seeking Alpha
Market Crash in the Cards? 3 Stocks to Book Profits - Investment Ideas 4:06 a.m. June 4, 2014 - Zacks.com
TG Therapeutics' (TGTX) CEO Michael Weiss on Q1 2014 Results - Earnings Call Transcript 1:31 p.m. May 13, 2014 - Seeking Alpha
The Recent Performance of 'Baker Brother Biotech Stocks' is Awful 12:23 p.m. April 15, 2014 - TheStreet.com
TG Therapeutics Gets A Triple Thumbs Up From The Baker Brothers 11:23 a.m. March 13, 2014 - Seeking Alpha
TG Therapeutics (TGTX) is Overbought, What's Next? - Tale of the Tape 9:35 a.m. March 13, 2014 - Zacks.com
Is It Too Late to Buy the Rally in Small Caps? 1:00 a.m. March 7, 2014 - InvestorPlace.com
TG Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 1:59 p.m. March 6, 2014 - Seeking Alpha
TG Therapeutics (TGTX) Worth Watching: Stock Up 6.6% - Tale of the Tape 10:25 a.m. Feb. 28, 2014 - Zacks.com
FDA Okays VIVO's Flu Assay, Shares Up - Analyst Blog 6:05 p.m. Jan. 14, 2014 - Zacks.com
TG Therapeutics initiates study of ublituximab/ PI3K Delta inhibitor combo 3:11 p.m. Nov. 25, 2013 - Seeking Alpha
Investments On Biotech's Cutting Edge: Joseph Pantginis 5:41 p.m. Nov. 18, 2013 - Seeking Alpha
TG Therapeutics, Inc. Enters Oversold Territory - Tale of the Tape 9:50 a.m. Nov. 18, 2013 - Zacks.com
TG Therapeutics' CEO Discusses Q3 2013 Results - Earnings Call Transcript 3:49 p.m. Nov. 12, 2013 - Seeking Alpha
10-Q: TG THERAPEUTICS, INC. 4:33 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
TG Therapeutics Completes Global Licensing Agreement With Ligand Pharmaceuticals for the Development of Inhibitors of IRAK4 8:09 a.m. Today - GlobeNewswire
Ligand Signs Global License Agreement with TG Therapeutics for IRAK-4 Inhibitor Program 3:01 a.m. Today - BusinessWire - BZX
TG Therapeutics, Inc. to Present at the 2014 JMP Securities Healthcare Conference 8:31 a.m. June 23, 2014 - GlobeNewswire
Sales, Clinical Hold Removal, Trial Initiations, and Committee Recommendations - Analyst Notes on Geron, Zalicus, Northwest Biotherapeutics, Progenics and TG Therapeutics 5:30 a.m. June 17, 2014 - PR Newswire - PRF
TG Therapeutics, Inc. to Present at the 2014 Wells Fargo Healthcare Conference 4:30 p.m. June 16, 2014 - GlobeNewswire
TG Therapeutics' TG-1101 (Ublituximab) in Combination With Ibrutinib Demonstrates Compelling Clinical Activity and Safety Profile in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) 5:31 a.m. June 13, 2014 - GlobeNewswire
Coronado Biosciences Announces February Inducement Award 4:06 p.m. May 9, 2014 - GlobeNewswire
TG Therapeutics, Inc. Provides Update on a Modified TGR-1202 Formulation and Fed-State Dosing With Data Demonstrating Significantly Higher TGR-1202 Exposure 8:32 a.m. May 8, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Present at the 39th Annual Deutsche Bank Healthcare Conference 8:32 a.m. May 5, 2014 - GlobeNewswire
TG Therapeutics, Inc. Announces Preclinical Poster Presentations for TGR-1202 at AACR 2014 8:32 a.m. April 7, 2014 - GlobeNewswire
TG Therapeutics, Inc. Announces $18.1 Million Underwritten Sale of Common Stock to a Single Institutional Investor 5:13 p.m. March 11, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Present at the 26th Annual ROTH Conference 10:01 a.m. March 10, 2014 - GlobeNewswire
TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results and Business Update 5:07 p.m. March 5, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2013 Financial Results and Business Update 9:31 a.m. March 4, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Present at the 16th Annual BIO CEO & Investor Conference 5:00 p.m. Feb. 7, 2014 - GlobeNewswire
TG Therapeutics, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference 5:30 p.m. Jan. 13, 2014 - GlobeNewswire
Coronado Biosciences Announces Management Changes 8:00 a.m. Dec. 20, 2013 - GlobeNewswire
TG Therapeutics, Inc. Announces Presentation of Encouraging Clinical Activity of TGR-1202 in an Ongoing Multi-Center Phase I Clinical Study 11:57 a.m. Dec. 9, 2013 - GlobeNewswire
TG Therapeutics, Inc. Launches Combination Clinical Trial of TG-1101 and Ibrutinib in Patients With Select B-Cell Malignancies 9:30 a.m. Dec. 6, 2013 - GlobeNewswire
TG Therapeutics, Inc. Announces Poster Presentations for TGR-1202 at the Upcoming 55th American Society of Hematology Meeting 5:40 p.m. Dec. 5, 2013 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼